Life Sciences Archive » June, 2007

Life Sciences - June, 2007

142 articles

• Sales Reps Sue Abbott For Overtime Pay
• Dey Buries Hatchet With States In Drug Pricing Suit
• Judge Issues Mixed Ruling In Chip Patent Case
• AstraZeneca Asserts Seroquel Patent Against Teva
• Federal Circuit Keeps Takeda's Win Streak Alive
• Stem Cell Patent Dispute Stayed Until PTO Ruling
• Doubt Cast On Anti-Depressant/Birth Defect Link
• University, Biotechs Squabble Over Genetic Testing
• AsymmetRx Sues Rivals Over Cancer Diagnostic Test
• GSK To Generics: Hands Off Paxil Patents
• FDA, SEC Disclosure: Standard Procedures Can Help
• Ortho Evra Plaintiffs' Lawyers Gear Up For Class Action
• A New Breed Of Products-Based Litigation
• J&J Wants Ortho Evra Documents Kept Under Wraps
• Pfizer Doesn't Owe Attorneys' Fees, Court Says
• Novogen Settles Patent Spat Over Menopause Patents
• Court Nixes Pfizer's Bid To Toss Nigeria Suit
• Bone Cancer Drug Suits Try To Break Novartis
• Supreme Court Will Hear Regulatory Preemption Case
• Purchasers Seek Class Status In Ditropan Case
• After Loss, Drug Makers Move To Toss Separate Case
• Battle Rages On In Seroquel Case
• Goldshield Pays £4M To Settle Price-Fixing Allegations
• Wyeth Wants To Dump Old PPA Case Files
• High Court Refuses To Hear Authorized Generics Suit
• Judge Tosses Ephedra Claim
• Wyeth Sues Sandoz Over Generic Effexor
• Tough Road Lies Ahead For Proposed Biologics Bill
• Teva Files Ninth Suit Over Heart Failure Drug
• Drug Middlemen Pan Judge Over Subpoena Denial
• Shelhigh Agrees To Halt Production Of Seized Devices
• Dewey Ballantine Grabs Three Robins Kaplan Partners
• J&J Unit Faces Scrutiny After $5M Jury Loss
• Teva Sues Over Congestive Heart Failure Drug
• Suits Contend Pfizer Drug Sparks Gambling Addiction
• Forest Cries Foul In Celexa/Lexapro Filing Chaos
• Judge Finds Drug Makers Liable For Inflating Costs
• Guidant Seeks To Exclude Testimony
• Litigator Reunites With Colleagues At Heller Ehrman
• DenTek Chomps Trade Secret Claims
• Alza Challenges Antitrust Claims In Ditropan Case
• Sanofi Fires New Round Of Infringement Claims
• Chemical Co. Sues Over Transdermal Patch Patent
• J&J Continues To Face Prosthetic Knee Suits
• Abbott Sues Impax Over Depakote
• Plaintiffs Win More Time To Seal Glaxo Deal
• Wyeth Loses First Diet Pill Trial Of 2007
• House Committee Greenlights Safety Bill
• Court Shakes Head At Novartis In Famvir Spat
• Bellwether Plaintiff Prepares For Guidant Trial
• Court Vacates Injunction In Pipe Fitting Patent Suit
• Biomedino's Blood-Cleaning Patent Found Invalid
• J&J Subsidiaries Hope For Another Dismissal
• Apotex To Appeal Court's Plavix Patent Ruling
• Israeli Co.'s Appeal Dies at the Supreme Court
• U.S., Europe Revamp Drug Regulation Pact
• Attacking Product Recall Evidence Under Daubert
• Becton Dickinson Sued Over Syringe Patents
• Forest Tries To Block Plaintiff In Celexa/Lexapro Suits
• Williams Bailey Tops List Of Suit-Happy Firms
• Alleged Vioxx Deception Earns Attys. $4M
• Judge Issues Blow To Accutane Plaintiffs
• Prempro Plaintiffs Demand Docs From Wyeth
• Judge Bounces Bextra, Celebrex Claims
• Sanofi Fights To Hang On To Eloxatin
• Tyco Unit Challenges OxyContin Patents
• Supplement Containing Impotence Drug Recalled
• State's Bid To Get Zyprexa Case On Home Turf Denied
• Vet Co. Sues Pfizer Over Drug Marketing Practices
• BMS Avoids Charge As Prosecution Deal Expires
• Merck Tops List In Pharma Class Actions
• Pharmaceutical Liability Will Turn On Preemption
• Eisai Patent Win Pains Antitrust Claimants
• Blame Over Fosamax Draws Sharp Debate
• F.D.A. Panel Rejects Drug for Obesity
• Plaintiffs Eye Punitive Pay Against Bausch & Lomb
• Bloomberg Moves To Unseal Guidant Court Papers
• Attorney Ads Make Mentally Ill Stop Taking Drugs: Lilly
• Ortho-McNeil, Plaintiffs Skirt Calif. Venue
• Pfizer Heaps Another $100M Onto Asbestos Trust
• KV Brings Antitrust Allegations To Patent Suit
• Judge Nixes Bids To Toss Heart Device Claims
• Suit Against Boston Scientific Officers Dismissed
• Warner Chilcott Drops $5.5M In Ovcon Settlement
• A Look at KSR
• Cordis, Abbott Continue Battle Over Stent Patents
• Autism Case Sparks Debate Over Vaccine Program
• High Court Nixes Pfizer's Bid For Quick Review
• Medtronic Asserts Corrected Claims Against Cordis
• ImClone Fires Counsel Following Sanctions
• Discovery In Seroquel Cases Gets OK
• Ortho-McNeil Denies Birth-Control Patch Claims
• Medtronic Braces For Face-Off In Court
• Lilly Settles Scores Of Zyprexa Suits
• GSK Faces More Headaches Over Avandia
• Bristol-Myers Bids To Exclude Evidence
• Judge Stays Schering Clarinex Patent Suit
• Court Sanctions ImClone, IP Attorneys
• Proveris Wins Permanent Injunction Against Rival
• Express Scripts Gets Fraud Charges Dismissed
• Purdue Sues KV Over OxyContin Patent
• Metabolife Settles More Ephedra Claims
• Teva, Novartis To Compete For Generic Lotrel
• Suit Alleges Biotech Firm Lied About FDA Trials
• Pfizer Seeks To Toss Celebrex, Bextra Cases
• Pfizer Sues Teva Over Lipitor Patent
• AstraZeneca Settlement Has Consumer Class Split
• AstraZeneca Hit With Wage-And-Hour Suit
• Plaintiffs Bash Broad Take On Twombly
• Court To Hear Ex-Employee's Case Against Pfizer
• Rite Aid Sued Over Alleged Union Suppression
• Proposed IP Protection Act Sparks Controversy
• Congress Weighs Value Of Pediatric Exclusivity
• Novartis Bone Drug Suit Grows
• Appraisal Arbitrage May Be A Hedge Fund Strategy
• Companies' Letter Demands Biologic Bill Passage
• Judge Denies Fresenius' Bid For Stay In Patent Case
• Appellate Court Remands ERISA Suit Against Guidant
• Defamation Suit Against J&J Moved To Federal Court
• Cordis Says Medtronic Stent Patents Unenforceable
• Consumers Urge High Court To Hear Tamoxifen Cases
• Pfizer Fights Bid To Keep Bextra Case In State Court
• Judge Rules Pepcid Complete Patent Is Invalid
• Union Sues J&J Over Off-Label Uses Of Risperdal
• Watson, Sun Seek Attorneys' Fees From Novartis
• Abbott Accused Of Inflating Drug Prices By 1000%
• Rite Aid Acquires 1,800+ Stores With Divestitures
• Nigeria Sues Pfizer For $7B Over Drug Trials
• FDA Commissioner Defends Reaction To Avandia
• FDA Proposes Committee For Risk Communication
• Circuit Reaffirms Invalidity of Pfizer's Norvasc Patent
• Proposed Inpatient Rule To Affect Specialty Hospitals
• Judge Says Impax, Apotex Infringed Prilosec Patents
• Lerach Awarded More Than $3M
• Merck Witness' Omission Leads To New Vioxx Trial
• Barr, Lilly Dismiss Prozac Patent Suit
• Abbott Accuses Health Officials In Medicare Suit
• EPA Probe Of Power Plant, Health Care Facility Waste
• Pfizer Asks For Quick Review In Norvasc Feud
• Express Scripts Sued Over Patient ID Cards
• Glaxo Slapped With Avandia Personal Injury Suit
• More Sales Reps Join Novartis Overtime Lawsuit